Interventional Devices & Therapies


Philips Volcano peripheral portfolio

Peripheral solutions that increase your imaging and therapy options

Contact information

* This field is mandatory

Contact details

*
*
*

Company details

*
*
*
*
*
*
*

Inquiry details

By specifying your reason for contact we will be able to provide you with a better service.
*
*
*
*

Philips announces the acquisition of CardioProlific Inc.

 

Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, announced the acquisition of CardioProlific Inc., a US-based, privately-held company that is developing catheter-based thrombectomy approaches to treat peripheral vascular disease.

 

Philips Volcano is the leader in image guided therapy and committed to working with health care providers to improve treatment for every patient. Our seamless integrated solutions advance minimally invasive procedures by helping clinicians to decide, guide, treat and confirm the right therapy for each patient at the point of care.

Below you can view the currently available peripheral products, related technologies, and a compatibility chart with Philips Volcano Core systems.

Peripheral

Compatibility with Philips Volcano systems and technologies

Core

Core

Core

Precision guided therapy system
Core Mobile

Core Mobile

Core Mobile

Precision guided therapy system

Peripheral imaging catheters

  • Visions .014P
  • Visions .018
  • Visions .035
  • Visions .014P
  • Visions .018
  • Visions .035

Re-entry system

  • Pioneer Plus
  • Pioneer Plus

Technologies

  • ChromaFlo (Visions .014P, Visions .018, and Pioneer Plus only)
  • IVUS
  • VH IVUS (PV .014P only)*
  • ChromaFlo (Visions .014P, Visions .018, and Pioneer Plus only)
  • IVUS
  • VH IVUS (PV .014P only)*

Atherectomy

  • The Phoenix atherectomy system is a stand-alone system that does not require Core or Core Mobile.
  • The Phoenix atherectomy system is a stand-alone system that does not require Core or Core Mobile.

Resources

Downloadable iOS app

*Safety and effectiveness of VH IVUS for use in the characterization of vascular lesions and tissue types has not been established.